14 March 2023 | News
The expansion will create 150 additional jobs in India
To meet the increasing demand in Asia, German firm SCHOTT has invested 75 million euros (approx. Rs 660 crore) over the last three years to expand its pharma glass production in India.
The Gujarat-based facility is the company’s manufacturing hub for borosilicate glass tubing, a high-quality material that is converted to pharmaceutical containers, such as vials, ampoules, or syringes, to store life-saving drugs.
At the official opening event recently, local government officials, business unit executives, and pharma industry representatives celebrated the start of a new production of FIOLAX amber pharmaceutical glass tubing.
With this move, manufacturers of drug containment solutions in the region can now receive SCHOTT’s complete portfolio of pharmaceutical glass tubing produced in India.
Amber glass is used to store light-sensitive medications such as antibiotics or chemotherapeutic agents. The local production will also improve availability, planning reliability, and cost efficiency for pharmaceutical converters.